According to the official website of the State Administration of drug administration, in March 15th, 2 COVID-19 antigen detection reagents were approved by the State Food and drug administration. As of March 16th, the State Administration of drug administration has approved 12 COVID-19 antigen detection reagents. The State Administration of Drug Administration said that COVID-19 antigen detection reagent is suitable for people who are prescribed by the COVID-19 antigen detection application plan (Trial Implementation) (joint prevention and control mechanism 2022 [21]). The drug regulatory department will strengthen the post marketing supervision of relevant products to protect the safety of patients. According to the data, on March 12, the State Food and Drug Administration issued a notice approving the application change of self-test application of neocoronavirus antigen products of Nanjing nuovizan, Beijing jinwofu, Shenzhen Huada Yinyuan, Guangzhou Wanfu biology and Beijing huaketai biology. On March 13, the State Food and Drug Administration approved the registration applications of five new coronavirus antigen products, namely Wantai biology, rejing biology, Tianjin boosses biology, Chongqing Mingdao jietest biology and Beijing Lepu diagnosis. (outlook new era)